Skip to main content
SpringerLink
Log in

Liver Dysfunction in a Patient with Ventricular Assist Device

  • Chapter
  • First Online:
Difficult Decisions in Cardiothoracic Critical Care Surgery

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY))

  • 947 Accesses

Abstract

Patients with severe or chronic heart failure (CHF) are at risk for hepatic ischemia due to poor global perfusion from left heart failure or for passive congestion from right heart failure, both of which can lead to significant liver dysfunction. In patients with left heart failure, perfusion of the liver tends to improve with ventricular assist device (VAD) implantation; a few patients, however, develop worse liver function post-VAD due to right heart failure, which can threaten patient survival. Identification of patients who need optimization of liver function prior to VAD and consideration of alternative strategies to improve liver function beyond standard of care before and after VAD placement are critical in optimizing patient outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.

    Article  CAS  PubMed  Google Scholar 

  2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–6.

    Article  PubMed  Google Scholar 

  3. Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61(22):2253–61.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261–9.

    Article  PubMed  Google Scholar 

  5. Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation. 2010;121(2):214–20.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bonde P, Ku NC, Genovese EA, Bermudez CA, Bhama JK, Ciarleglio MM, et al. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy. Ann Thorac Surg. 2012;93(5):1541–7. discussion 7–8

    Article  PubMed  Google Scholar 

  7. Deo SV, Daly RC, Altarabsheh SE, Hasin T, Zhao Y, Shah IK, et al. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation. ASAIO J. 2013;59(1):57–62.

    Article  PubMed  Google Scholar 

  8. Tsiouris A, Paone G, Nemeh HW, Borgi J, Williams CT, Lanfear DE, et al. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices. World J Cardiol. 2015;7(11):792–800.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yost GL, Coyle L, Bhat G, Tatooles AJ. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices. J Artif Organs. 2016;19(1):21–8.

    Article  PubMed  Google Scholar 

  10. Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, et al. MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13(1):30–7.

    Article  PubMed  Google Scholar 

  11. Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant. 2012;31(6):601–10.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec ventricular assist device principal investigators. J Heart Lung Transplant. 1994;13(6):1125–32.

    CAS  PubMed  Google Scholar 

  13. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122(6):1186–95.

    Article  CAS  PubMed  Google Scholar 

  14. Kamdar F, Boyle A, Liao K, Colvin-Adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28(4):352–9.

    Article  PubMed  Google Scholar 

  15. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation. 2009;120(23):2352–7.

    Article  PubMed  Google Scholar 

  16. Deo SV, Sharma V, Altarabsheh SE, Hasin T, Dillon J, Shah IK, et al. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ. 2014;23(3):229–33.

    Article  PubMed  Google Scholar 

  17. Yoshioka D, Takayama H, Colombo PC, Yuzefpolskaya M, Garan AR, Topkara VK, et al. Changes in end-organ function in patients with prolonged continuous-flow left ventricular assist device support. Ann Thorac Surg. 2017;103(3):717–24.

    Article  PubMed  Google Scholar 

  18. Weymann A, Patil NP, Sabashnikov A, Mohite PN, Garcia Saez D, Bireta C, et al. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far? Artif Organs. 2015;39(4):336–42.

    Article  CAS  PubMed  Google Scholar 

  19. Demirozu ZT, Hernandez R, Mallidi HR, Singh SK, Radovancevic R, Segura AM, et al. HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction. J Card Surg. 2014;29(3):419–23.

    Article  PubMed  Google Scholar 

  20. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J. 2013;77(1):96–104.

    Article  CAS  PubMed  Google Scholar 

  21. Maxhera B, Albert A, Ansari E, Godehardt E, Lichtenberg A, Saeed D. Survival predictors in ventricular assist device patients with prior extracorporeal life support: selecting appropriate candidates. Artif Organs. 2014;38(9):727–32.

    Article  PubMed  Google Scholar 

  22. Kaplon RJ, Gillinov AM, Smedira NG, Kottke-Marchant K, Wang IW, Goormastic M, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant. 1999;18(4):346–50.

    Article  CAS  PubMed  Google Scholar 

  23. Kato TS, Kitada S, Yang J, Wu C, Takayama H, Naka Y, et al. Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2013;112(9):1484–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Maltais S, Stulak JM. Right and left ventricular assist devices support and liver dysfunction: prognostic and therapeutic implications. Curr Opin Cardiol. 2016;31(3):287–91.

    Article  PubMed  Google Scholar 

  25. Dandel M, Krabatsch T, Falk V. Left ventricular vs. biventricular mechanical support: decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation. Int J Cardiol. 2015;198:241–50.

    Article  PubMed  Google Scholar 

  26. Argiriou M, Kolokotron SM, Sakellaridis T, Argiriou O, Charitos C, Zarogoulidis P, et al. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014;6(Suppl 1):S52–9.

    PubMed  PubMed Central  Google Scholar 

  27. Scherer M, Moritz A, Martens S. The use of extracorporeal membrane oxygenation in patients with therapy refractory cardiogenic shock as a bridge to implantable left ventricular assist device and perioperative right heart support. J Artif Organs. 2009;12(3):160–5.

    Article  CAS  PubMed  Google Scholar 

  28. Durinka JB, Bogar LJ, Hirose H, Brehm C, Koerner MM, Pae WE, et al. End-organ recovery is key to success for extracorporeal membrane oxygenation as a bridge to implantable left ventricular assist device. ASAIO J. 2014;60(2):189–92.

    Article  CAS  PubMed  Google Scholar 

  29. Riebandt J, Haberl T, Mahr S, Laufer G, Rajek A, Steinlechner B, et al. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg. 2014;46(3):486–92. discussion 92

    Article  PubMed  Google Scholar 

  30. Marasco SF, Lo C, Murphy D, Summerhayes R, Quayle M, Zimmet A, et al. Extracorporeal life support bridge to ventricular assist device: the double bridge strategy. Artif Organs. 2016;40(1):100–6.

    Article  PubMed  Google Scholar 

  31. Shah P, Pagani FD, Desai SS, Rongione AJ, Maltais S, Haglund NA, et al. Outcomes of patients receiving temporary circulatory support before durable ventricular assist device. Ann Thorac Surg. 2017;103(1):106–12.

    Article  PubMed  Google Scholar 

  32. Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant. 2015;34(9):1123–30.

    Article  PubMed  Google Scholar 

  33. Nishi H, Toda K, Miyagawa S, Yoshikawa Y, Fukushima S, Yoshioka D, et al. Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation. J Artif Organs. 2013;16(4):404–10.

    Article  PubMed  Google Scholar 

  34. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25(1):1–6.

    Article  PubMed  Google Scholar 

  35. Aissaoui N, Morshuis M, Schoenbrodt M, Hakim Meibodi K, Kizner L, Borgermann J, et al. Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients. J Thorac Cardiovasc Surg. 2013;146(1):186–91.

    Article  PubMed  Google Scholar 

  36. Deschka H, Holthaus AJ, Sindermann JR, Welp H, Schlarb D, Monsefi N, et al. Can perioperative right ventricular support prevent postoperative right heart failure in patients with biventricular dysfunction undergoing left ventricular assist device implantation? J Cardiothorac Vasc Anesth. 2016;30(3):619–26.

    Article  PubMed  Google Scholar 

  37. Kaczorowski DJ, Woo YJ. Who needs an RVAD in addition to an LVAD? Cardiol Clin. 2011;29(4):599–605.

    Article  PubMed  Google Scholar 

  38. Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP, et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant. 2014;33(2):141–8.

    Article  PubMed  Google Scholar 

  39. Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–60.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Chicago Medicine, Chicago, IL, USA

    Helen S. Te

Authors
  1. Helen S. Te
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen S. Te .

Editor information

Editors and Affiliations

  1. University of Chicago Medicine, Chicago, IL, USA

    Vassyl A. Lonchyna

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Te, H.S. (2019). Liver Dysfunction in a Patient with Ventricular Assist Device. In: Lonchyna, V. (eds) Difficult Decisions in Cardiothoracic Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-04146-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04146-5_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04145-8

  • Online ISBN: 978-3-030-04146-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation